Merck loses interest in Seagen
![Photo: Joost Melis / Genmab / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14323296.ece/ALTERNATES/schema-16_9/doc7mde5m69q0hqjmp766v.jpg)
Seagen, which had been a potential acquisition target for Merck, is reportedly no longer of interest to the pharmaceutical giant.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
MSD eyeing Seagen acquisition, media reports
For subscribers